API Butenafine hydrochloride

Butenafine hydrochloride More Info

Butenafine hydrochloride is a synthetic antifungal medication mainly used to treat superficial fungal infections of the skin. It falls under the allylamine class of antifungals, a group recognized for their broad-spectrum activity and specific mechanism targeting fungal cell membrane synthesis.

1. Core Basic Information

Chemical Class: It is an allylamine derivative.

Molecular Formula: C₂₁H₂₈ClN.

Mode of Action: This medication works by inhibiting fungal squalene epoxidase, a key enzyme critical for ergosterol synthesis. Ergosterol is indispensable for maintaining the integrity of the fungal cell membrane. When ergosterol production is disrupted, the fungal cell membrane becomes damaged, toxic squalene accumulates inside the cell, and this ultimately leads to fungal cell death.

Spectrum of Activity: It has broad-spectrum antifungal effects, active against various pathogens including:

Dermatophytes (such as Trichophyton, Microsporum, Epidermophyton—these are common causes of conditions like ringworm, athlete’s foot, and jock itch).

Some yeasts (e.g., Candida species, which can cause cutaneous candidiasis).

Certain molds associated with skin infections.

2. Clinical Uses

Butenafine hydrochloride is primarily formulated as a topical cream or solution for external use, targeting localized superficial fungal infections. Its main indications include:

Tinea pedis (Athlete’s Foot): Especially effective for interdigital (between the toes) and plantar (sole of the foot) types of athlete’s foot caused by dermatophytes.

Tinea cruris (Jock Itch): Treats fungal infections in the groin and inner thigh area, which are often triggered by moisture and friction.

Tinea corporis (Ringworm): Addresses circular, itchy, scaly rashes on the body, face, or limbs caused by dermatophyte invasion.

Cutaneous candidiasis: In some cases, it is used to treat yeast infections of the skin (caused by Candida), such as diaper rash or intertrigo (skin fold infections).

3. Administration and Dosage

Route of Administration: Exclusive to topical use—applied directly to the affected skin and the surrounding healthy skin (usually 1-2 cm beyond the lesion edge) to prevent recurrence.

Typical Dosage: Generally applied once daily, though the frequency and duration may vary based on the infection type and severity. For example, athlete’s foot may require 2-4 weeks of treatment, while ringworm might need 2 weeks.

Key Instructions: The affected area should be cleaned and dried thoroughly before application. Avoid contact with eyes, mouth, nose, and other mucous membranes. If the infection does not improve after the recommended course or worsens, medical advice should be sought.

4. Adverse Reactions

Most users tolerate butenafine hydrochloride well, with adverse reactions typically being mild and localized to the application site. Common ones include:

Mild burning, stinging, or itching.

Redness, dryness, or peeling of the skin.

Severe adverse reactions are rare but may include severe skin irritation, rash, hives, or swelling. If any severe reaction occurs, discontinue use immediately and consult a healthcare provider.

5. Contraindications and Precautions

Contraindications: Individuals with a known hypersensitivity to butenafine hydrochloride or any components of the formulation should not use it.

Special Populations:

Pregnant and breastfeeding women should use it only under the guidance of a doctor, as data on its safety in these groups is limited.

It is generally not recommended for use in infants (specific age restrictions may vary by product), and pediatric use should be supervised by a healthcare provider.

Other Precautions:

Do not use on broken, damaged, or severely inflamed skin unless directed by a doctor.

If the infection spreads or symptoms persist, seek medical evaluation to rule out other underlying conditions.

Keep out of reach of children. If accidentally ingested, seek emergency medical attention immediately.

6. Key Distinctions from Similar Antifungals

As an allylamine, butenafine hydrochloride differs from azole antifungals (e.g., clotrimazole, miconazole) in several ways:

Mechanism: Allylamines target squalene epoxidase (early in ergosterol synthesis), while azoles inhibit lanosterol 14α-demethylase (later in the pathway).

Potency: Butenafine often has higher antifungal activity against dermatophytes and a longer skin retention time, allowing for shorter treatment courses in some cases.

Spectrum: It has broader activity against certain dermatophytes and some yeasts compared to some azoles.